DS Stage II Plasma Cell Myeloma Completed Phase 2 Trials for Clarithromycin (DB01211)

Back to DS Stage II Plasma Cell Myeloma
IndicationStatusPhase
DBCOND0030429 (DS Stage II Plasma Cell Myeloma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00445692Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple MyelomaTreatment